We are live on !
Find out more
XTL Biopharmaceuticals
XTLB
XTLB
1.73
USD
+0.03
1.76%
At close
Updated
Nov 3, 4:00 PM EST
Pre-market
After hours
1.73
0.00
0%
1 day
1.76%
5 days
-2.81%
1 month
-20.64%
3 months
-39.51%
6 months
-54.71%
Year to date
-27.92%
1 year
-58.81%
5 years
-89.11%
10 years
-89.32%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
1
Invesco
Atlanta,
Georgia
| $68K | -$11 | -1 | -0% |
|
| 2 |
2
Morgan Stanley
New York
| $15K | +$13.7K | +1,220 | +718% |
|
| 3 |
3
UBS Group
Zurich,
Switzerland
| $14K | +$5.41K | +483 | +57% |
|
| 4 |
SM
4
Sabby Management
Miami Beach,
Florida
| – | -$434K | -36,207 | Closed |
|
| 5 |
5
Citadel Advisors
Miami,
Florida
| – | -$50K | -4,159 | Closed |
|